Biostar Pharmaceuticals (BSPM) Reports Q3 Earnings of $0.16; Reaffirms Outlook

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q3 EPS of $0.16, versus $0.13 reported last year. Revenue for the quarter came in at $24.78 million, versus $20.18 million reported last year.

Reaffirms outlook.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c